arrow
T

Todd D. Prickett

National Cancer Institute
H指数:40
被引数:9,548

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers

鉴定在患有上皮癌的患者中针对共享PIK3CA突变的HLA-II类限制性T细胞受体

2025-12-180
OAAI
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results

转移性结直肠癌中个性化新抗原反应性TCR转导T细胞的过继转移: 2期试验中期结果

2024-07-114
OA
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes

肿瘤浸润淋巴细胞的新抗原特异性刺激可实现有效的TCR隔离和扩增,同时保留干细胞样记忆表型

2024-05-302
OAAI
IMPACT restrains immuno-metabolic GCN1 signaling to govern pancreatic cancer metastasis
2024-01-160
PRE
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
MED
IF11.8
2022-10-0125
OA
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
2020-10-05289
OA
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2019-08-01207
OAAI
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

体细胞突变的免疫识别导致转移性乳腺癌的完全持久消退

2018-06-04639
OAAI